CoChat
Cited by 62

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Imaging of incidentally discovered adrenal masses

Open access
Peppercorn, P. D., Grossman, A. B., Reznek, R. H. · 1998 · Clinical Endocrinology

Abstract

In the last decade the increased use of cross-sectional imaging, especially computed tomography (CT) and magnetic resonance imaging (MRI), has led to an increase in the number of incidentally discovered adrenal masses. Even in patients with a known malignancy, the majority of these will be benign, nonhyperfunctioning adenomas ( Oliver et al., 1984 ). Rapidly evolving imaging techniques used to evaluate these masses has meant that intervention is now indicated in only a minority of patients. The approach to their investigation must include a consideration of several factors including: diagnostic costs, discomfort to the patient, risks from biopsy, consequences of false-positive results, and disease prevalence. This article reviews the imaging appearances of the most common causes of an incidentally discovered adrenal mass, and suggests a strategy for the investigation of such masses. Adrenal masses of varying pathology are found in 0.35-4.4% of patients imaged with CT for reasons other than suspected adrenal pathology ( Glazer et al., 1982 ; Prinz et al., 1982 ; Abeccassis et al., 1985 ; Belldegrun et al., 1986 ; Herrera et al., 1991 ), and are usually referred to as adrenal ‘incidentalomas’. Large autopsy series of more than 1000 patients report a slightly higher incidence of 1.4-5.7% ( Russi & Blumenthal, 1945; Devenyi, 1967; Kokko et al., 1967 ; Granger & Genest, 1970; Russel et al., 1972 ; Commons & Callaway, 1984). It is likely that with the increased use of abdominal CT and MRI, improving spatial resolution, and the use of thinner slices, there will be a further increase in the prevalence of such incidentally discovered adrenal masses. The vast majority of truly incidental adrenal masses (i.e. those discovered in patients with no other pathology) are adrenal adenomas. The incidence of other adrenal masses such as myelolipomas, adrenal cysts, phaeochromocytomas, carcinoma and metastases varies considerably in the literature depending on the size of the series ( Kloos et al., 1995 ). Even in patients known to have malignant disease, adrenal adenomas are often more common than metastases ( Oliver et al., 1984 ). The first step in investigating an adrenal mass detected incidentally is to establish whether it is biochemically active. If shown to be biochemically active the mass is dealt with accordingly. If the mass is not hyperfunctioning a substantial differential diagnosis remains. Some of these masses, such as myelolipomas and cysts, have specific imaging features which may allow characterization of the mass on imaging alone. In patients with an adrenal mass which cannot be characterized on imaging alone, the problem is then to differentiate benign from malignant lesions. In patients with a known malignancy the differential diagnosis is essentially between adrenal metastases and an adrenal adenoma, whilst in patients without a known malignancy adrenal carcinoma must also be considered. The major hyper-secretory syndromes associated with adrenal masses are Cushing's syndrome, Conn's syndrome and phaeochromocytomas. Cushing's syndrome may be clinically obvious, and can be confirmed by grossly elevated urinary free cortisol or, with greater sensitivity, by a failure of serum cortisol at 0900 h to suppress to < 50 nmol/l in the standard low-dose dexamethasone suppression test ( Perry & Grossman, 1997). However, it may be noted that some, possibly the majority, of ‘nonfunctioning’ adenomas may also show a failure of suppression, although presumably in these cases the overall secretory rate remains below or within the normal range ( Tsagarakis et al., 1998 ). Patients with Conn's syndrome will demonstrate hypokalaemic alkalosis, although this may be masked by a low sodium diet: further investigation will reveal a suppressed plasma renin and elevated aldosterone:renin ratio ( Vallotton, 1996b). Such tumours are usually small and have the signal characteristics of adenomas. Finally, secretory phaeochromocytomas can be identified by elevated urinary catecholamine excretion using either GCMS or HPLC with electrochemical detection: the sensitivity of this technique currently approaches 100% ( Ross et al., 1993 ; Bouloux & Fakeeh, 1995). The majority of incidentally discovered adrenal masses are nonhyperfunctioning benign adrenal adenomas, representing 36-94% of all adrenal masses in patients without a known malignancy ( Abecassis et al., 1985 , Prinz et al., 1982 , Mitnick et al., 1983 ; Guerrero, 1985; Bitter & Ross, 1989; Hubbard et al., 1989 ; Siren et al., 1993 ). The reported prevalence of adrenal adenomas at autopsy varies widely, but is as high as 68% ( Bruger et al., 1944 ; Shamman et al., 1958 ). Adrenal adenomas consist of cords of clear cells separated by fibrovascular tissue. The number and size of these nodules increase with age ( Doppman et al., 1989 ), and they occur with increased frequency in obese diabetic patients and elderly women ( Gross et al., 1987 ). On CT these nodules are characteristical

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1998.00475.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 62

Metadata

Authors
Peppercorn, P. D., Grossman, A. B., & Reznek, R. H.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1998-04
Volume
48
Issue
4
Pages
379-388
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2003679971
Cited by
62
References
7
FWCI
6.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Imaging of incidentally discovered adrenal masses. https://app.cochat.ai/papers/10.1046/j.1365-2265.1998.00475.x
The paper
Peppercorn, P. D., Grossman, A. B., & Reznek, R. H. (1998). Imaging of incidentally discovered adrenal masses. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1998.00475.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.